Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia

作者: Lekshmy Srinivas , Neetha N. Vellichirammal , Ann Mary Alex , Chandrasekharan Nair , Indu V. Nair

DOI: 10.1186/S12974-016-0569-8

关键词: Neurotrophic factorsHaplotypeAlleleSchizophreniaCytokineImmunologyProinflammatory cytokineGenetic predispositionPhenotypeBiology

摘要: In schizophrenia, genetic background may provide a substrate for intrinsic maldevelopment of the brain through environmental influences, by recruiting neurotrophic factors and cytokines, to trigger changes that lead impaired neuronal functions. Cytokines being key regulators immune/inflammatory reactions are also known influence dopaminergic, noradrenergic, serotonergic neurotransmission. Therefore, functional polymorphisms in cytokine genes result imbalances pro- anti-inflammatory production. We screened using case-control association study South Indian population. The role allele, genotype, haplotype, diplotypes these their epistatic interactions were assessed contributing risk developing schizophrenia. Meta-analysis reported associations was monitored global significance. pro-inflammatory gene IL1Ars1800587, IL6rs1800796, TNFArs361525, IFNGrs2069718 associated with provides significant evidence strong among IL6 IFNG development silico analysis suggested variants indicative altered transcriptional activity higher production IL1α, IL-6, TNF-α, IFN-ɤ cytokines. indicated heterogeneity population while IL1Ars1800587 found be globally significant. It is important identify nature inflammatory response can amplified environment, either Th1 or Th2 response. involved increased expression resulting cytokines IL-1α, IFN-γ. interaction immunological stressors high producer alleles suggest even lower threshold sufficient induce resultant chronic effect on psycho-social pathogenesis Understanding possibly help dissecting phenotypic variation therapeutic antipsychotics

参考文章(53)
Marc-André Roy, Xavier Devriendt, [Positive and negative symptoms in schizophrenia: a current overview]. The Canadian Journal of Psychiatry. ,vol. 39, pp. 407- 414 ,(1994) , 10.1177/070674379403900704
Yuichiro Watanabe, Toshiyuki Someya, Hiroyuki Nawa, Cytokine hypothesis of schizophrenia pathogenesis: Evidence from human studies and animal models Psychiatry and Clinical Neurosciences. ,vol. 64, pp. 217- 230 ,(2010) , 10.1111/J.1440-1819.2010.02094.X
Yiquan Chen, Gilles J. Guillemin, Kynurenine Pathway Metabolites in Humans: Disease and Healthy States: International Journal of Tryptophan Research. ,vol. 2, pp. 1- 19 ,(2009) , 10.4137/IJTR.S2097
Sibylle G. Schwab, Stephanie Mondabon, Michael Knapp, Margot Albus, Joachim Hallmayer, Margitta Borrmann-Hassenbach, Matyas Trixler, Magdalena Groβ, Thomas G. Schulze, Marcella Rietschel, Bernard Lerer, Wolfgang Maier, Dieter B. Wildenauer, Association of tumor necrosis factor alpha gene -G308A polymorphism with schizophrenia Schizophrenia Research. ,vol. 65, pp. 19- 25 ,(2003) , 10.1016/S0920-9964(02)00534-0
Sylvian Bauer, Bradley J. Kerr, Paul H. Patterson, The neuropoietic cytokine family in development, plasticity, disease and injury Nature Reviews Neuroscience. ,vol. 8, pp. 221- 232 ,(2007) , 10.1038/NRN2054
Anna D. Inglot, Jerzy Leszek, Egbert Piasecki, Alicja Sypula, Interferon responses in schizophrenia and major depressive disorders Biological Psychiatry. ,vol. 35, pp. 464- 473 ,(1994) , 10.1016/0006-3223(94)90045-0
Monika Paul-Samojedny, Malgorzata Kowalczyk, Renata Suchanek, Aleksander Owczarek, Anna Fila-Danilow, Aleksandra Szczygiel, Jan Kowalski, Functional Polymorphism in the Interleukin-6 and Interleukin-10 Genes in Patients with Paranoid Schizophrenia —A Case-Control Study Journal of Molecular Neuroscience. ,vol. 42, pp. 112- 119 ,(2010) , 10.1007/S12031-010-9365-6
Justin D Penner, Alan S Brown, Prenatal infectious and nutritional factors and risk of adult schizophrenia. Expert Review of Neurotherapeutics. ,vol. 7, pp. 797- 805 ,(2007) , 10.1586/14737175.7.7.797
R. Zakharyan, M. Petrek, A. Arakelyan, F. Mrazek, S. Atshemyan, A. Boyajyan, Interleukin-6 promoter polymorphism and plasma levels in patients with schizophrenia. Tissue Antigens. ,vol. 80, pp. 136- 142 ,(2012) , 10.1111/J.1399-0039.2012.01886.X